← Infrastructure Secondaries Daily

BCI Says Single-Asset CVs Are 20–30% of Its Deal Flow (June 11, 2026)

June 11, 2026 · 14m 8s · Listen

BCI says single-asset continuation vehicles now make up 20 to 30 percent of its deal flow — a remarkable number to put on the record with no reference date attached to the marks underneath. And this is Infrastructure Secondaries Daily — today’s cluster all comes back to the same question: who's actually getting served when the liquidity shows up. Westfield Retirement Board just launched a secondaries RFP, BCI is standing up a Capital Solutions Group, and Houlihan Lokey pushed GP-led into real estate. Let's start with Westfield. Because an RFP from a public retirement board doesn't land like a neutral process document. It tells every buyer in the room the board needs liquidity. That's the part I want to sit with. Here's my problem before we even get to urgency. Westfield is evaluating portfolios it wants to acquire — fine. But what reference-date NAV are they pricing those against? Without that, every discount quoted back at them is a marketing sentence. Right, and flip it to the seller's side. The RFP itself telegraphs the timeline. Buyers see a board that has to transact, and they price that urgency straight into the bid. So put it in dollars. If the Commonfund framework from yesterday's Step Back says you're tendering at, what, fifteen points off a stale appraisal, that's beneficiary money walking out the door. I don't call that a clean exit. And the people taking that haircut are pensioners who never voted for a liquidity mandate that forces a fire sale. The market knows they can't wait. It always knows. That gets us to the LP-to-continuation-vehicle pivot — the Secondaries Investor piece. LPs are choosing to roll into CVs instead of selling. To me, that's the sharpest pricing signal in today's rundown. Why, though? Are the CVs winning on asset quality, or are secondary bids just landing below where LPs carry the thing? Exactly. If secondary pricing still lags GP marks, the CV starts looking like the better deal by default — not because the underlying assets earned it. And BCI's 20-to-30 percent single-asset number sits right in that gap. And BCI is the part that genuinely bothers me structurally. They're a pension LP turning themselves into a GP financier. That's role compression — the same GPs they're bankrolling may also run assets BCI holds as a limited partner. So where's the conflict language? A Capital Solutions Group press release tells me they have capability. It doesn't tell me how they wall off the financing arm from the LP book. It doesn't, because that paragraph always shows up later — section seven, after the deal's already closed. Houlihan just teed up the same move in real estate. Say more on Houlihan, because the question writes itself. They expand GP-led advisory with a senior hire — so who issues the fairness opinion when the firm building the deal flow is also the placement agent? That's the whole game. The adviser originating the GP-led is the adviser you then ask to bless it. Infra secondaries has been arguing about that for years, and real estate just inherited the same architecture in one press release. And a fairness opinion only has teeth if the LPAC sees it well before the deadline. Two weeks, minimum. Any tighter and the vote is theater. So that's the line through all of it: BCI on one side as the LP turned financier, Houlihan on the other as the adviser turned originator. Watch the disclosure that comes next. That's where we'll see who these deals were actually written for. From Headlines Briefing:

The Westfield Retirement Board has issued a formal request for proposals to acquire private‑equity secondaries. By launching the RFP, the board signals intent to redeploy capital from mature holdings into more liquid assets. Investors will now compete to offer portfolios that match Westfield’s risk tolerance and expected return profile.

So everyone's reading this as Westfield wanting liquidity — but look at the RFP language. They're soliciting proposals to acquire secondaries. Westfield is on the buy side here, pricing risk on the other end of the trade. Right, the board wants to redeploy out of mature holdings and into secondaries. So I'd ask them this: when you evaluate the buyout, growth, and distressed bundles people send back, what reference-date NAV are you marking them against? Exactly. Targeting an 8 to 10 percent IRR is fine, but every discount or premium quoted back to Westfield is meaningless until you know the as-of date on the NAV underneath it. Without that, it's just marketing. And the RFP process broadcasts something on its own. A public retirement board publicly shopping for portfolios tells every counterparty exactly how much appetite is in the room, and counterparties price that. Several hundred million into the pipeline, per PE International, doesn't move quietly. When a big investor sells an infrastructure stake on the secondary market, what actually sets the price — is it buyer return targets, the cost of debt, how the fund was appraised, or something else entirely? Honestly, it's all of those things stacked together. Per Commonfund, secondary pricing is quoted as a percentage of NAV. So a $10 million position trading at 90% of NAV means the buyer pays $9 million. And the spread can be huge: high-quality buyout interests can trade above NAV, while lower-quality, overvalued interests can see discounts of 70% or steeper. In infrastructure, the valuation fight adds another wrinkle. UBS notes that critics think rising rates should push infrastructure discount rates higher and bring appraisal values down. But the asset class hasn't seen widespread write-downs — private infrastructure equity was still up roughly 10% in 2022 and about 4% in the first half of 2023, per MSCI and Burgiss. That gap — between the GP appraiser's value and what a buyer believes it's worth in a higher-rate world — is where secondary discounts get negotiated. Then Joran Partners adds the fund-level pieces: uncalled capital, vintage year, portfolio concentration, and whether the GP's consent-to-transfer rights create friction or delay that the buyer has to price in. So if there's been no write-down but buyers think rates should have pushed values lower, does infrastructure basically trade at a structural discount right now compared with other asset classes? That's the tension to watch. Alter Domus says infrastructure secondaries have moved from a niche tool to a permanent market mechanism because long-duration cash flows don't fit neatly inside fixed fund lifespans. So more supply keeps hitting the market, no matter where buyers think NAV should be. With deal volume around $25 billion in 2025 — a record year, per Allianz Global Investors — we'll find out whether that supply overhang pushes GPs toward appraisal adjustments, or whether buyers blink first and chase deals at tighter discounts. From Andreea Melinti at Private Equity Insights:

Salon described the shift in BCI’s pipeline as striking. Between 20% and 30% of the pension fund’s current deal flow is now made up of single-asset continuation vehicles, up from roughly 5% two years ago.

So BCI — a public pension, the LP — is standing up a Capital Solutions Group to finance the very GPs whose continuation vehicles it may be voting on as an LP. Jon Salon calls it being a 'capital solutions provider to our general partners.' That's role compression worth saying out loud. Preferred equity, recaps, CV financing — that's the menu, per the May 29 Bloomberg report. Every one of those instruments prices off NAV, Daniel, and none of them works without a reference date attached to the mark they're financing against. And here's the conflict I can't get past — the same GP whose liquidity BCI is solving may run a fund BCI holds as an LP. Whose interest gets served first when those two seats are at the same table? The slowdown is real — exits choked, IPOs constrained, that's the backdrop the article leans on. But when BCI underwrites CVs to manufacture distributions, it's betting the marks are good. Show me the as-of date, then we'll talk about whether it's a lifeline or a bridge to a number that's already moved. The press release frames it as a lifeline. From a pensioner's chair, it's a pension fund deciding the highest-return use of beneficiaries' capital is bankrolling GPs who can't sell. Here's HeadlinesBriefing:

Limited partners are pivoting toward continuation vehicles while expressing skepticism about LP-led secondaries, marking a notable shift in private markets sentiment. Investors increasingly favor maintaining exposure to quality assets rather than pursuing exits in volatile conditions.

This Secondaries Investor piece from June 4th is the pricing signal hiding in plain sight. When Florida SBA and Sweden's Alecta both back away from LP-leds and toward continuation vehicles, I want to know whether CVs are winning on asset quality — or just winning because the secondary bid is still lagging GP marks. And notice who's making the pivot — Florida SBA, a public pension. When the people closest to the liquidity mandate say the LP-led return doesn't clear their bar, I listen. But the single-asset CV framing makes me nervous, Cass. 'Trusting the GP to hold the proven performer' is exactly the sentence you hear right before a continuation fund built for the GP's carry, with the LP's optionality dead last. Right — and 'proven performer' comes with no reference date. Proven as of when? At what NAV? If the LP is choosing to roll rather than sell, somebody's comparing two prices, and I'd like to see both dated before we call it a vote of confidence. A CV does let an investor cash out or roll forward — on paper, that's optionality. The catch is that the cash-out gets priced against the same stale mark the seller is trying to escape. So the 'choice' isn't symmetric. Here's Business Wire:

Houlihan Lokey, Inc. (NYSE: HLI), the global investment bank, announced today that Bodo Krug von Nidda has joined the firm as a Managing Director in its Capital Solutions Group. Mr. Krug von Nidda is based in New York and will collaborate with his partners in Equity Capital Solutions and Real Estate Capital Advisory to focus on GP-Led Secondaries advisory.

Houlihan Lokey just hired Bodo Krug von Nidda from PJT Park Hill to build out GP-led secondaries in real estate. Read the press release — all capability, all platform. Not one word about how conflicts get handled when the same desk originates the deal. Gregg Newman calls it 'highly bespoke private capital solutions.' Bespoke is a lovely word for a deal where the adviser building the flow is also the one you'd ask for the fairness opinion. That's the architecture I want flagged now, before the deals land. Real estate is inheriting the conflict map infrastructure secondaries has been living with for years — the same adviser originates the deal, gives the advice, and then opines on fairness. And property NAVs are appraisal-driven, so the reference-date question is even sharper than it is in buyout. Call it bespoke if you want, but a real estate GP-led priced off a mark that's two quarters stale is underwriting optimism. Tie any premium or discount to an as-of date, or you're just dressing up a sentence with a percentage sign. Right — and per Business Wire, this whole move is the industry porting buyout-style secondaries onto property. Fine. Just put the conflict language in paragraph one, not section seven. Got a question, correction, or deal trend you think we should be watching? Send it our way at infrastructuresecondariesdaily at lantern podcasts dot com. We read every note, and your feedback helps shape the briefing.

You’ll find links to every story we covered today in the show notes. If one caught your ear, it's there for a closer read.

That’s Infrastructure Secondaries Daily for this Thursday, June 11th. This is a Lantern Podcast.